ReShape Lifesciences Inc. (RSLS) Reports Q2 Net Loss of $7.8M
Tweet
Share
E-mailGet Alerts RSLS Hot Sheet
Join SI Premium – FREE
ReShape Lifesciences Inc. (NASDAQ: RSLS) reported Q2 net loss of $7.8 million. Revenue for the quarter came in at $2.9 million versus the consensus estimate of $3.41 million.
For earnings history and earnings-related data on ReShape Lifesciences Inc. (RSLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
